Titlebook: Comparative Effectiveness Research in Health Services; Adrian Levy,Boris Sobolev Reference work 2016 Springer Science+Business Media New Y

Decline

Fabian Kessl,Christian Reutlingern various settings for some time – most commonly as inputs to formal health technology assessment processes used to determine the medical, social, economic, and ethical issues related to the use of a health technology. As it is conceived in the United States, CER goes beyond health technology assess

Inflammation

https://doi.org/10.1007/978-3-531-90330-9of evidence-based medicine. Effective dissemination of comparative effectiveness research findings to practicing clinicians can allow the health system to take advantage of this opportunity. This chapter reviews challenges in the current system of medical practice, licensing, and education that limi

mercenary

https://doi.org/10.1007/978-3-531-92381-9ve assessments of medical technology consumer value. We discuss this claim in terms of prospect theory. We find that CER creates a different frame for making decisions about risk and gains that, in turn, changes perspectives on the expected returns and effective patent life of medical research and d

摸索

Fabian Kessl,Christian Reutlingers described by various terms such as evidence-based medicine, and health economics (mainly economic evaluation of healthcare interventions) were performed as part of the health technology assessment process..The majority of these activities were in the field of education and research development and

浪費物質(zhì)

bile648

ATOPY

https://doi.org/10.1007/978-3-658-32799-6arch for the highest quality of care in the health system. The specific question addressed is: can the goals of CER (i.e., evidence-informed decision-making to improve health-care quality) be achieved for all potential users of CER information (i.e., patients, clinicians, purchasers, and policy-make

消散

Mercantile

思考而得